CataCap

    Invest In Arcade Therapeutics

    OtherOther
    Gender EquityGender Equity
    Arcade Therapeutics
    3 investors
    Evergreen

    Funding Progress

    $53,500 of a $500,000 goal

    Be One of the First Investors — early movers shape the outcome

    $

    Invest: Minimum ($5000)

    About Arcade Therapeutics

    Arcade Therapeutics: Transforming Women's Mental Health with Therapeutic Games


    Women experience anxiety at twice the rate of men, are twice as likely to face depression, and 1 in 5 experience postpartum depression — yet 75% of maternal mental health conditions go untreated. Arcade Therapeutics is changing that with a first-of-its-kind platform that turns clinically proven mental health treatment into something women actually want to use: a casual mobile game.


    Arcade Therapeutics first product, StarStarter, uses Attention Bias Modification (ABM) — a neuroscience-backed technique validated across 7 NIH-funded clinical trials — to retrain how the brain responds to anxiety. Just 6–12 minutes a day over 30 days. No prescription required. In its clinical study, 90% of users saw a reduction in anxiety symptoms, with an average improvement of 33%. Its most recent findings were published in the Journal of Anxiety Disorders.


    Arcade is not just a product — it is building a platform. ArcadeConnect™, its AI-driven clinical insights layer, enables real-time mood tracking and automated escalation to higher levels of care, making us a compelling partner for health systems, universities, and employer programs alike.


    Where we are today:

    • Launched direct-to-consumer subscriptions in February 2026, exceeding early projections
    • First app to earn the APA Digital Badge for clinical quality
    • Signed enterprise contracts with Montclair State University, Atlantic Health System, Talkspace, and others rolling out in 2026
    • $3.8M NIMH grant co-awarded with UT Austin Dell Medical School to expand into depression treatment
    • Backed by Anne Wojcicki (Founder, 23andMe), SeedLinx, Blu Venture Investors, and BAT VC

    Arcade is raising a $1.5M Seed Extension to scale our DTC launch, staff commercial operations, and reach $1–2M ARR — positioning us for a Series A growth round. The investment accelerates access to mental health care for millions of women who are underserved, overlooked, and overdue for something better.

    Themes & SDGs Supported

    Other
    Other
    Gender Equity
    Gender Equity
    Good Health and Well-Being
    Good Health and Well-Being
    Gender Equality
    Gender Equality

    Mission and Vision

    Arcade Therapeutics is reinventing the mental health journey with science-backed therapeutic games. By combining cognitive neuroscience with immersive gameplay, we are building a new category of digital therapeutics that drive earlier intervention, better adherence, and improved outcomes at scale. Our vision is to become the leading platform for digital mental health and AI-driven triage—expanding from anxiety and depression into a full ecosystem of game-based treatments that transform how care is accessed, delivered, and experienced worldwide.

    Investment Terms

    To view Terms/Materials, you must have a CataCap account and be logged in. Access to full materials is available to Donor/Investors with an active CataCap balance.

    If you do not have an active balance, you may contact the company or fund directly using the “Questions about this investment?” link, or email [email protected] for assistance.

    Investment Materials

    To view Materials/Terms, you must have a CataCap account and be logged in. Access to full materials is available to Donor/Investors with an active CataCap balance.

    If you do not have an active balance, you may contact the company or fund directly using the “Questions about this investment?” link, or email [email protected] for assistance.